Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W9PG
|
||||
| Former ID |
DIB016590
|
||||
| Drug Name |
Pyrazinoylguanidine
|
||||
| Synonyms |
PZG
|
||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [545139] | ||
| Company |
Sparta Pharmaceuticals Inc
|
||||
| Canonical SMILES |
N(C(=O)c1nccnc1)C(=N)N
|
||||
| CAS Number |
CAS 60398-24-5
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [528291] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.